{
    "organizations": [],
    "uuid": "6f28eef76bb12f4ad620dc30df67558eb56492df",
    "author": "",
    "url": "https://www.reuters.com/article/brief-proteostasis-receives-endorsement/brief-proteostasis-receives-endorsement-from-cystic-fibrosis-foundation-for-study-of-pti-428-in-cf-subjects-on-background-symdeko-therapy-idUSFWN1RU0OV",
    "ord_in_thread": 0,
    "title": "BRIEF-Proteostasis Receives Endorsement From Cystic Fibrosis Foundation For Study Of PTI-428 In CF Subjects On Background Symdeko Therapy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News April 17, 2018 / 12:08 PM / Updated 10 minutes ago BRIEF-Proteostasis Receives Endorsement From Cystic Fibrosis Foundation For Study Of PTI-428 In CF Subjects On Background Symdeko Therapy Reuters Staff 1 Min Read \nApril 17 (Reuters) - Proteostasis Therapeutics Inc: \n* PROTEOSTASIS RECEIVES ENDORSEMENT FROM THE CYSTIC FIBROSIS FOUNDATION’S THERAPEUTIC DEVELOPMENT NETWORK FOR THE STUDY OF THE COMPANY’S AMPLIFIER, PTI-428, IN CF SUBJECTS ON BACKGROUND SYMDEKO™ THERAPY Source text for Eikon: Further company coverage:",
    "published": "2018-04-17T15:08:00.000+03:00",
    "crawled": "2018-04-17T15:21:47.023+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "receives",
        "endorsement",
        "cystic",
        "fibrosis",
        "foundation",
        "study",
        "cf",
        "subject",
        "background",
        "symdeko",
        "therapy",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "proteostasis",
        "therapeutic",
        "inc",
        "proteostasis",
        "receives",
        "endorsement",
        "cystic",
        "fibrosis",
        "foundation",
        "therapeutic",
        "development",
        "network",
        "study",
        "company",
        "amplifier",
        "cf",
        "subject",
        "background",
        "therapy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}